Continuity of Care, Structural Inequities and Neonatal Outcomes among Pregnant Women with Sickle Cell Disease in Uganda: A Mixed-Methods Study

Pregnancy is a time of profound change, but for women living with sickle cell disease, it carries a heavy, specific burden. Sickle cell disease is an inherited condition where the blood cells, which normally act like flexible discs carrying oxygen, become stiff and shaped like crescent moons. These misshapen cells can get stuck in tiny blood vessels, blocking the flow of oxygen and causing sudden, severe pain known as crises. When a woman with this condition becomes pregnant, her body faces the dual challenge of managing a chronic illness while supporting a growing baby. In many parts of the world, particularly in sub-Saharan Africa where the condition is most common, the path to a healthy birth is often blocked not just by the disease itself, but by the way the healthcare system is built. Women may face delays in getting blood, long journeys to clinics, or a lack of coordinated care, all of which can turn a manageable pregnancy into a life-threatening one.

Researchers in Uganda recently set out to understand exactly how these different factors interact. They wanted to know what actually protects a baby and mother in this high-risk situation. Is it the woman's education or her job? Is it the support of her husband? Or is it something more practical, like simply being able to see the same doctors regularly without interruption? To find the answer, a team of doctors and scientists from several Ugandan universities and hospitals followed a group of 140 pregnant women with sickle cell disease. They tracked these women from the moment they were enrolled in the study through the birth of their babies, collecting detailed medical records and asking the women about their experiences. They also spoke privately with dozens of these women and the healthcare providers who cared for them, listening to stories about fear, hope, and the daily struggles of navigating a broken system.

The study revealed a clear and powerful pattern: the most important factor for a healthy outcome was continuity of care. This term describes a smooth, unbroken journey through the healthcare system. It means a woman can easily get to her appointments, sees her doctors frequently, and follows their advice without gaps. The researchers found that women who maintained this steady connection with their care team were significantly less likely to experience tragic outcomes, such as the loss of the baby or the need for the newborn to be admitted to a special care unit. In fact, the data showed that for every step a woman took toward better continuity, her risk of a bad outcome dropped sharply. This protection held true even when the researchers accounted for other factors like how severe the woman's disease was or how much support she had at home.

In contrast, the study found that the usual markers of social advantage did not offer the same shield. Having a secondary education, holding a job, or being married did not, on their own, guarantee a safer pregnancy or a healthier baby. While these factors are important in many areas of life, the researchers discovered that in the context of sickle cell disease in Uganda, they could not overcome the barriers of a fragmented health system. A woman with a degree but no access to consistent medical care was just as likely to face a crisis as a woman without one. The only social factor that showed a clear link to better outcomes was the involvement of a partner. Women whose partners were actively involved in their care tended to have better continuity, likely because a supportive partner helped them navigate the logistics of getting to the hospital and sticking to their treatment plan.

The numbers told a stark story about the disease itself. Women who suffered three or more painful crises during their pregnancy faced a much higher risk of adverse outcomes compared to those who had fewer or none. This confirmed that the biological severity of the condition is a major driver of risk. However, the human stories gathered by the researchers added a crucial layer of understanding to these statistics. Many women described being discouraged from becoming pregnant by doctors or family members who told them it was too dangerous. Some spoke of being shamed or abandoned by partners once the pregnancy was known. Others recounted the frustration of being sent from one hospital to another, losing time and money, or arriving at a clinic only to find that the necessary blood or medicine was missing.

The healthcare providers interviewed shared their own heavy burden. They described a deep sense of moral distress, feeling helpless when they could not save a patient because the tools they needed were simply not there. They spoke of the emotional toll of watching women deteriorate due to shortages of pain medication or blood products, and the frustration of having no clear national guidelines to follow. These stories illuminated why continuity of care is so fragile; it is not just a matter of a woman's will to attend appointments, but a system that must be reliable enough to keep her there. When the system fails with delays, costs, and shortages, the continuity breaks, and the risk to the mother and baby rises.

The researchers concluded that to improve the lives of these women, the focus must shift from simply hoping for better individual circumstances to fixing the system itself. The evidence suggests that policies should prioritize building a care pathway that is seamless and reliable. This means ensuring that blood supplies are available, that referrals between hospitals are fast and coordinated, and that financial barriers do not stop a woman from getting the care she needs. It also means training healthcare workers to treat these women with respect and without judgment, rather than discouraging them from motherhood. While the disease itself presents a severe challenge, the study makes it clear that the tragedy of poor outcomes is not inevitable. By strengthening the continuity of care and addressing the structural gaps in the health system, it is possible to protect both mothers and their newborns, turning a high-risk pregnancy into a journey with a much brighter chance of success.